EconPapers    
Economics at your fingertips  
 

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma

Balazs Acs, Fahad Shabbir Ahmed, Swati Gupta, Pok Fai Wong, Robyn D. Gartrell, Jaya Sarin Pradhan, Emanuelle M. Rizk, Bonnie Gould Rothberg, Yvonne M. Saenger and David L. Rimm ()
Additional contact information
Balazs Acs: Yale School of Medicine
Fahad Shabbir Ahmed: Yale School of Medicine
Swati Gupta: Yale School of Medicine
Pok Fai Wong: Yale School of Medicine
Robyn D. Gartrell: Columbia University Medical Center/New York Presbyterian
Jaya Sarin Pradhan: Columbia University Irving Medical Center/New York Presbyterian
Emanuelle M. Rizk: Columbia University Irving Medical Center/New York Presbyterian
Bonnie Gould Rothberg: Yale School of Medicine
Yvonne M. Saenger: Columbia University Irving Medical Center/New York Presbyterian
David L. Rimm: Yale School of Medicine

Nature Communications, 2019, vol. 10, issue 1, 1-7

Abstract: Abstract Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxylin-eosin stained sections in melanoma. Using a retrospective collection of 641 melanoma patients comprising four independent cohorts; one training set (N = 227) and three validation cohorts (N = 137, N = 201, N = 76) from 2 institutions, we show that the automated TIL scoring algorithm separates patients into favorable and poor prognosis cohorts, where higher TILs scores were associated with favorable prognosis. In multivariable analyses, automated TIL scores show an independent association with disease-specific overall survival. Therefore, the open source, automated TIL scoring is an independent prognostic marker in melanoma. With further study, we believe that this algorithm could be useful to define a subset of patients that could potentially be spared immunotherapy.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-019-13043-2 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13043-2

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-13043-2

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13043-2